GUJARAT KIDNEY N SUP SP L (GKSL) financials
GUJARAT KIDNEY N SUP SP L (GKSL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
- Market Cap: ₹1,414Cr.
- Current Price: ₹179
- Stock P/E: 176
- ROE: 7.28%
- ROCE: 9.33%
- Book Value: ₹31.3
- Dividend Yield: 0.00%
- 52W High / Low: ₹210/98.2
In Jun 2026, GUJARAT KIDNEY N SUP SP L (GKSL) reported sales ₹9.24 Cr and net profit ₹2.04 Cr.
Annual TTM: sales ₹37.88 Cr, net profit ₹8.04 Cr.
Shareholding: Promoters 71.45% (Sep 2026), FIIs 6.52% (Sep 2026), DIIs 0.25% (Sep 2026), Public 21.77% (Sep 2026), No. of Shareholders 12,986% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 9.41 | 8.51 | 8.02 | 11.45 | 9.64 | 9.76 | 9.24 | 9.24 |
| Expenses | 4.55 | 4.70 | 5.71 | 5.12 | 5.55 | 5.62 | 7.66 | 6.25 |
| Operating Profit | 4.86 | 3.81 | 2.31 | 6.33 | 4.09 | 4.14 | 1.58 | 2.99 |
| OPM % | 51.65% | 44.77% | 28.80% | 55.28% | 42.43% | 42.42% | 17.10% | 32.36% |
| Other Income | 0.04 | 0.02 | 0.04 | 0.00 | 0.02 | 0.03 | 0.45 | 0.65 |
| Interest | 0.16 | 0.11 | 0.12 | 0.13 | 0.23 | 0.29 | 0.50 | 0.35 |
| Depreciation | 0.74 | 0.66 | 0.75 | 0.80 | 0.75 | 0.72 | 0.67 | 0.64 |
| Profit before tax | 4.00 | 3.06 | 1.48 | 5.40 | 3.13 | 3.16 | 0.86 | 2.65 |
| Tax % | 26.25% | 27.78% | 14.19% | 27.78% | 26.20% | 26.27% | -59.30% | 23.02% |
| Net Profit | 2.96 | 2.21 | 1.26 | 3.90 | 2.30 | 2.33 | 1.37 | 2.04 |
| EPS in Rs | 0.53 | 0.39 | 0.22 | 0.69 | 0.40 | 0.30 | 0.17 | 0.26 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 0.00 | 4.77 | 35.17 | 40.10 | 37.88 |
| Expenses | 0.01 | 3.20 | 19.73 | 23.95 | 25.08 |
| Operating Profit | -0.01 | 1.57 | 15.44 | 16.15 | 12.80 |
| OPM % | — | 32.91% | 43.90% | 40.27% | 33.79% |
| Other Income | 0.00 | 0.70 | 0.11 | 0.49 | 1.15 |
| Interest | 0.00 | 0.04 | 0.53 | 1.15 | 1.37 |
| Depreciation | 0.00 | 0.28 | 2.93 | 2.94 | 2.78 |
| Profit before tax | -0.01 | 1.95 | 12.09 | 12.55 | 9.80 |
| Tax % | 0.00% | 25.13% | 24.73% | 21.12% | — |
| Net Profit | -0.01 | 1.45 | 9.11 | 9.90 | 8.04 |
| EPS in Rs | -0.00 | 0.41 | 1.60 | 1.26 | 1.13 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | — |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 11.37 | 15.77 |
| Reserves | 0.17 | 10.69 | 14.05 | 230.69 |
| Borrowings | 0.00 | 1.94 | 5.48 | 16.08 |
| Other Liabilities | 3.50 | 3.99 | 18.18 | 3.53 |
| Total Liabilities | 3.87 | 16.82 | 49.08 | 266.07 |
| Fixed Assets | 2.67 | 9.74 | 28.42 | 25.71 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.00 | 1.51 | 108.58 |
| Other Assets | 1.19 | 7.08 | 19.15 | 131.78 |
| Total Assets | 3.87 | 16.82 | 49.08 | 266.07 |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from Operating Activity | 0.00 | -2.11 | 15.36 | -7.46 |
| Cash from Investing Activity | 0.00 | -7.35 | -19.43 | -213.76 |
| Cash from Financing Activity | 0.00 | 10.63 | 4.80 | 226.94 |
| Net Cash Flow | 0.00 | 1.17 | 0.73 | 5.72 |
| Free Cash Flow | 0.00 | -9.46 | -2.62 | -66.68 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 0% | -100% | 115% | -22% |
| Category | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Promoters | 71.45% | 71.45% | 71.45% | 71.45% |
| FIIs | 10.47% | 4.89% | 4.89% | 6.52% |
| DIIs | 1.67% | 0.56% | 0.56% | 0.25% |
| Public | 16.40% | 23.10% | 23.10% | 21.77% |
| No. of Shareholders | 27,783 | 18,301 | 18,301 | 12,986 |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | — | 318.32 | 132.84 | 171.85 |
| Inventory Days | — | 317.90 | — | — |
| Days Payable | — | 2,825.81 | — | — |
| Cash Conversion Cycle | — | -2,189.58 | 132.84 | 171.85 |
| Working Capital Days | — | 114.01 | -26.88 | 54.07 |
| ROCE % | — | 19.55% | 57.72% | 9.33% |
Gujarat Kidney N Sup Sp L
₹1,414Cr.
₹179
₹210/98.2
176
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of GUJARAT KIDNEY N SUP SP L (GKSL)?
The reported market capitalisation for GUJARAT KIDNEY N SUP SP L (GKSL) is ₹1,414Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of GKSL?
The current price shown for GUJARAT KIDNEY N SUP SP L (GKSL) on Fincrux is ₹179 with a 52-week high/low of ₹210/98.2.
What is the P/E ratio of GUJARAT KIDNEY N SUP SP L (GKSL)?
The stock P/E for GUJARAT KIDNEY N SUP SP L (GKSL) is 176 on Fincrux, with ROE at 7.28% and ROCE at 9.33%.
What were GKSL latest quarterly results?
For Jun 2026, GUJARAT KIDNEY N SUP SP L (GKSL) reported sales ₹9.24 Cr and net profit ₹2.04 Cr (figures in ₹ crore unless noted).
What are GKSL annual sales and net profit?
For TTM, GUJARAT KIDNEY N SUP SP L (GKSL) shows sales of ₹37.88 Cr and net profit of ₹8.04 Cr on the Fincrux profit & loss statement.
Who owns GUJARAT KIDNEY N SUP SP L (GKSL)?
Latest shareholding for GUJARAT KIDNEY N SUP SP L (GKSL) on Fincrux: Promoters 71.45% (Sep 2026), FIIs 6.52% (Sep 2026), DIIs 0.25% (Sep 2026), Public 21.77% (Sep 2026), No. of Shareholders 12,986% (Sep 2026).
Where can I find GUJARAT KIDNEY N SUP SP L (GKSL) financials?
GUJARAT KIDNEY N SUP SP L (GKSL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show GKSL balance sheet and cash flow?
Yes. The GUJARAT KIDNEY N SUP SP L (GKSL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.